Middleton & Co’s iShares Biotechnology ETF IBB Stock Holding History

Middleton & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$608K	Hold	3,600	–	–	0.07%	109
2025 Q4	$608K	Hold	3,600	–	–	0.06%	104
2025 Q3	$520K	Hold	3,600	–	–	0.06%	113
2025 Q2	$455K	Hold	3,600	–	–	0.05%	119
2025 Q1	$460K	Hold	3,600	–	–	0.05%	115
2024 Q4	$476K	Hold	3,600	–	–	0.05%	110
2024 Q3	$524K	Hold	3,600	–	–	0.06%	111
2024 Q2	$494K	Hold	3,600	–	–	0.06%	109
2024 Q1	$494K	Hold	3,600	–	–	0.06%	114
2023 Q4	$489K	Hold	3,600	–	–	0.06%	106
2023 Q3	$440K	Hold	3,600	–	–	0.06%	106
2023 Q2	$457K	Hold	3,600	–	–	0.06%	110
2023 Q1	$465K	Hold	3,600	–	–	0.07%	109
2022 Q4	$473K	Hold	3,600	–	–	0.07%	111
2022 Q3	$421K	Sell	3,600 -225	-6%	-$27.9K	0.06%	108
2022 Q2	$450K	Hold	3,825	–	–	0.06%	115
2022 Q1	$498K	Hold	3,825	–	–	0.05%	120
2021 Q4	$584K	Sell	3,825 -600	-14%	-$92.9K	0.06%	120
2021 Q3	$715K	Hold	4,425	–	–	0.08%	107
2021 Q2	$724K	Hold	4,425	–	–	0.08%	105
2021 Q1	$666K	Buy	+4,425	New	+$703K	0.08%	106

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Middleton & Co's IBB Position: Q1 2026 in Review

Middleton & Co held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 3,600 shares worth $608K. The position accounts for 0.07% of the portfolio, ranked #109.

Middleton & Co first reported a position in IBB in Q1 2021 and has held it in 21 quarters since. The position peaked at $724K in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Middleton & Co held 3,600 shares of iShares Biotechnology ETF worth $608K as of Q1 2026.
Middleton & Co left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.07% of Middleton & Co's portfolio in Q1 2026, its #109 holding.
Middleton & Co first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 21 quarters since.
Middleton & Co's iShares Biotechnology ETF position peaked at $724K in Q2 2021.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.